Last week, the House Committee on Energy and Commerce (E&C) held a markup of 44 legislative proposals related to the nation’s energy, health care, consumer protections and national security needs. Chairwoman Rogers (R-WA) highlighted the high cost Americans still continue to pay for health care despite lagging performance in life expectancy and patient outcomes when compared to peer nations. Of the bills under consideration, 19 were relating to health care—all of which have been advanced. Many of the bills advanced focus on improving transparency and reducing unnecessary health care costs. No additional action is expected on these bills in 2023. Keep reading for a full list of health care bills that are moving forward.

• H.R. 2365, National Plan to End Parkinson’s Act
• H.R. 5372, Expanding Seniors’ Access to Lower Cost Medicines Act of 2023
• H.R. 2880, Protecting Patients Against PBM Abuses Act
• H.R. 5393, To ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes
• H.R. 5385, Medicare PBM Accountability Act
• H.R. 5386, Cutting Copays Act
• H.R. 4881, To limit cost sharing for drugs under the Medicare program.
• H.R. 5389, National Coverage Determination Transparency Act
• H.R. 133, Mandating Exclusive Review of Individual Treatments (MERIT) Act
• H.R. 5396, Coverage Determination Clarity Act of 2023
• H.R. 5371, Choices for Increased Mobility Act of 2023
• H.R. 5388, Supporting Innovation for Seniors Act
• H.R. 5380, To increase data transparency for supplemental benefits under Medicare Advantage.
• H.R. 3842, Expanding Access to Diabetes Self-Management Training Act of 2023
• H.R. 5397, Joe Fiandra Access to Home Infusion Act of 2023
• H.R. 5555, DMEPOS Relief Act of 2023
• H.R. 6545, Physician Fee Schedule Update and Improvements Act
• H.R. 6364, Medicare Telehealth Privacy Act of 2023
• H.R. 1352, Increasing Access to Biosimilars Act of 2023